January 2009

Subscriptions

Features

Pharmaceuticals

Get Ready, Get Set, Get E-Prescribing

With the new year comes a Medicare incentive for prescribe drugs electronically. Will you be among the early adopters?

Future Advances in Glaucoma Therapy

Today’s research—gene therapy, stem cell transplants, neuroprotective drugs and ‘real-time’ pressure monitoring—will help tomorrow’s glaucoma patients.

Individualized Drugs for Individual Needs

There are several ocular conditions in which patients might benefit from using compounded therapeutics.

Special Report

Credit Relief in a Sick Economy

In this ailing economy, take care of your loans and avoid getting caught in the credit crunch.

Departments

Chairside

One Old Guy’s Perspective

As optometrists, we know that the appearance of an object can change depending on your point of view. How about taking a new point of view?

Clinical Quandaries

Stop Prostaglandin for Cataract?

In glaucoma patients, prostaglandins are linked to cystoid macular edema after cataract surgery. When is it time to just say no?

Coding Connection

How Fast a Year Goes!

We covered a lot of ground last year. Now it’s time to move forward. Do this by revving up your coding practices.

Cornea and Contact Lens Q & A

Viral Trouble, Doubled

A young teen presents with bilateral viral infection. Is there a chance of malignancy?

Diagnostic Quiz

Is This a Bad Connection?

Letters to the Editor

Meetings and Conferences

Meetings + Conferences

News Review

How Will Obama Affect Optometry?

Not well, say many O.D.s. Still, his programs might give optometry a boost.

Switch to ICD-10 Will Cost You

In the News

Outlook

When the Going Gets Tough

In the spirit of “change,” let’s make the best use of this New Year.

Product Review

Retina Quiz

The Diagnosis Could Be Worse

This patient presented with blurred vision in her left eye. The findings looked rather serious at first. But, is the diagnosis actually that bad?

Review of Systems

Is AMD Really a Systemic Disease?

Only when clinicians and researchers began to view AMD beyond the retina did significant advances occur.

Therapeutic Review

Epiphora Epiphany

Chronic epiphora is often difficult to pin down. Unlike acute cases, the cause in these situations may not be apparent.